Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer.
Patrinely JR Jr, Dewan AK, Johnson DB. Patrinely JR Jr, et al. Among authors: dewan ak. BioDrugs. 2020 Aug;34(4):495-503. doi: 10.1007/s40259-020-00428-9. BioDrugs. 2020. PMID: 32447657 Free PMC article. Clinical Trial.
Cutaneous adverse events caused by immune checkpoint inhibitors.
Quach HT, Johnson DB, LeBoeuf NR, Zwerner JP, Dewan AK. Quach HT, et al. Among authors: dewan ak. J Am Acad Dermatol. 2021 Oct;85(4):956-966. doi: 10.1016/j.jaad.2020.09.054. Epub 2021 Jul 28. J Am Acad Dermatol. 2021. PMID: 34332798 Review.
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.
Halle BR, Betof Warner A, Zaman FY, Haydon A, Bhave P, Dewan AK, Ye F, Irlmeier R, Mehta P, Kurtansky NR, Lacouture ME, Hassel JC, Choi JS, Sosman JA, Chandra S, Otto TS, Sullivan R, Mooradian MJ, Chen ST, Dimitriou F, Long G, Carlino M, Menzies A, Johnson DB, Rotemberg VM. Halle BR, et al. Among authors: dewan ak. J Immunother Cancer. 2021 Oct;9(10):e003066. doi: 10.1136/jitc-2021-003066. J Immunother Cancer. 2021. PMID: 34635495 Free PMC article.
Cost assessment in melanoma clinical trials: A cross-sectional study.
Goodman RS, Garner DC, Koester S, Patrinely JR Jr, Dewan AK, Johnson DB. Goodman RS, et al. Among authors: dewan ak. JAAD Int. 2023 May 26;12:139-141. doi: 10.1016/j.jdin.2023.05.005. eCollection 2023 Sep. JAAD Int. 2023. PMID: 37409320 Free PMC article. No abstract available.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Chen ST, et al. Among authors: dewan ak. J Immunother Cancer. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675. J Immunother Cancer. 2024. PMID: 38599660 Free PMC article.
101 results